Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors

Brain, Behavior, and Immunity

Volumn 30, Issue SUPPL., 2013, Pages

  Kesler, Shelli ^a   Janelsins, Michelle ^b   Koovakkattu, Della ^a   Palesh, Oxana ^a   Mustian, Karen ^b   Morrow, Gary ^b   Dhabhar, Firdaus S ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Breast cancer; Chemotherapy; Hippocampus; Interleukin 6; Memory; MRI; Tumor necrosis factor alpha

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; INTERLEUKIN 6; METHOTREXATE; PACLITAXEL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BRAIN SIZE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HIPPOCAMPAL VOLUME; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VERBAL MEMORY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HIPPOCAMPUS; HUMANS; INTERLEUKIN-6; MAGNETIC RESONANCE IMAGING; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SURVIVORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84875367121     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.05.017     Document Type: Article

References (103)

1. Abercrombie H.C., Giese-Davis J., Sephton S., Epel E.S., Turner-Cobb J.M., Spiegel D. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 2004, 29:1082-1092.
2. Aghakhani, A., Chan, E.K., 2007. Test Reviews: Bracken, B.A., Howell, K. (2004). Clinical Assessment of Depression. Odessa, FL: Psychological Assessment Resources. J. Psycho. Assess. 25, 416-422.
3. Ahles T.A., Saykin A.J. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat. Rev. Cancer 2007, 7:192-201.
4. Ahles T.A., Saykin A.J., Furstenberg C.T., Cole B., Mott L.A., Skalla K., Whedon M.B., Bivens S., Mitchell T., Greenberg E.R., Silberfarb P.M. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J. Clin. Oncol. 2002, 20:485-493.
5. Ahles T.A., Saykin A.J., McDonald B.C., Li Y., Furstenberg C.T., Hanscom B.S., Mulrooney T.J., Schwartz G.N., Kaufman P.A. Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve. J. Clin. Oncol. 2010, 28:4434-4440.
6. Ahles T.A., Saykin A.J., Noll W.W., Furstenberg C.T., Guerin S., Cole B., Mott L.A. The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy. Psycho-oncology 2003, 12:612-619.
7. Aluise C.D., Miriyala S., Noel T., Sultana R., Jungsuwadee P., Taylor T.J., Cai J., Pierce W.M., Vore M., Moscow J.A., St Clair D.K., Butterfield D.A. 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-alpha release: implications for the reactive oxygen species-mediated mechanisms of chemobrain. Free Radical Biol. Med. 2011, 50:1630-1638.
8. Anthony D.C., Bolton S.J., Fearn S., Perry V.H. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 1997, 120(Pt 3):435-444.
9. Aye, T., Park, Y., Kesler, S., Reiss, A.L., Schleifer, K., Baumgartner, H., Hoang, S., Wilson, D.M., Drobny, J., Buckingham, B.A., 2011. The feasibility of detecting neuropsychologic and neuroanatomic effects of type 1 diabetes in young children. Diabetes Care 34, 1458-1462.
10. Bartko J.J. The intraclass correlation coefficient as a measure of reliability. Psychol. Rep. 1966, 19:3-11.
11. Bauer S., Kerr B.J., Patterson P.H. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat. Rev. Neurosci. 2007, 8:221-232.
12. Bergouignan L., Lefranc J.P., Chupin M., Morel N., Spano J.P., Fossati P. Breast cancer affects both the hippocampus volume and the episodic autobiographical memory retrieval. PLoS One 2011, 6:e25349.
13. Boulware M.I., Kent B.A., Frick K.M. The impact of age-related ovarian hormone loss on cognitive and neural function 2011, Curr. Top. Behav. Neurosci.
14. Bower J.E., Ganz P.A., Aziz N., Fahey J.L. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom. Med. 2002, 64:604-611.
15. Bower J.E., Ganz P.A., Tao M.L., Hu W., Belin T.R., Sepah S., Cole S., Aziz N. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin. Cancer Res.: J. Am. Assoc.Cancer Res 2009, 15:5534-5540.
16. Brown E.S., D J.W., Frol A., Bobadilla L., Khan D.A., Hanczyc M., Rush A.J., Fleckenstein J., Babcock E., Cullum C.M. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol. Psychiatry 2004, 55:538-545.
17. Correa D.D., Ahles T.A. Neurocognitive changes in cancer survivors. Cancer J. 2008, 14:396-400.
18. Czlonkowska A., Ciesielska A., Gromadzka G., Kurkowska-Jastrzebska I. Estrogen and cytokines production - the possible cause of gender differences in neurological diseases. Curr. Pharm. Des. 2005, 11:1017-1030.
19. Das S., Basu A. Inflammation: a new candidate in modulating adult neurogenesis. J. Neurosci. Res. 2008, 86:1199-1208.
20. de Ruiter M.B., Reneman L., Boogerd W., Veltman D.J., van Dam F.S., Nederveen A.J., Boven E., Schagen S.B. Cerebral hyporesponsiveness and cognitive impairment 10years after chemotherapy for breast cancer. Hum. Brain Mapp. 2011, 32:1206-1219.
21. Deeken J.F., Loscher W. The blood-brain barrier and cancer: transporters, treatment, and Trojan horses. Clin. Cancer Res. 2007, 13:1663-1674.
22. Deprez S., Amant F., Smeets A., Peeters R., Leemans A., Van Hecke W., Verhoeven J.S., Christiaens M.R., Vandenberghe J., Vandenbulcke M., Sunaert S. longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. J. Clin. Oncol. 2012, 30:274-281.
23. Deprez S., Amant F., Yigit R., Porke K., Verhoeven J., Van den Stock J., Smeets A., Christiaens M.R., Leemans A., Van Hecke W., Vandenberghe J., Vandenbulcke M., Sunaert S. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients. Hum. Brain Mapp. 2011, 32:480-493.
24. Dietrich J. Chemotherapy associated central nervous system damage. Adv. Exp. Med. Biol. 2010, 678:77-85.
25. Dietrich J., Han R., Yang Y., Mayer-Proschel M., Noble M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J. Biol. 2006, 5:22.
26. Du X.L., Xia R., Hardy D. Relationship between chemotherapy use and cognitive impairments in older women with breast cancer: findings from a large population-based cohort. Am. J. Clin. Oncol. 2010, 33:533-543.
27. Eberling J.L., Wu C., Haan M.N., Mungas D., Buonocore M., Jagust W.J. Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol. Aging 2003, 24:725-732.
28. Eberling J.L., Wu C., Tong-Turnbeaugh R., Jagust W.J. Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage 2004, 21:364-371.
29. Erickson K., Drevets W., Schulkin J. Glucocorticoid regulation of diverse cognitive functions in normal and pathological emotional states. Neurosci. Biobehav. Rev. 2003, 27:233-246.
30. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., Gage F.H. Neurogenesis in the adult human hippocampus. Nat. Med. 1998, 4:1313-1317.
31. Fardell J.E., Vardy J., Logge W., Johnston I. Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents. Pharmacol. Biochem. Behav. 2010, 97:333-339.
32. Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., van der Kouwe A., Killiany R., Kennedy D., Klaveness S., Montillo A., Makris N., Rosen B., Dale A.M. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002, 33:341-355.
33. Fischl B., van der Kouwe A., Destrieux C., Halgren E., Segonne F., Salat D.H., Busa E., Seidman L.J., Goldstein J., Kennedy D., Caviness V., Makris N., Rosen B., Dale A.M. Automatically parcellating the human cerebral cortex. Cereb. Cortex 2004, 14:11-22.
34. Funk J.A., Gohlke J., Kraft A.D., McPherson C.A., Collins J.B., Jean Harry G. Voluntary exercise protects hippocampal neurons from trimethyltin injury: possible role of interleukin-6 to modulate tumor necrosis factor receptor-mediated neurotoxicity. Brain Behav. Immun. 2011, 25:1063-1077.
35. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
36. Geinitz H., Zimmermann F.B., Stoll P., Thamm R., Kaffenberger W., Ansorg K., Keller M., Busch R., van Beuningen D., Molls M. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001, 51:691-698.
37. Giese-Davis J., Sephton S.E., Abercrombie H.C., Duran R.E., Spiegel D. Repression and high anxiety are associated with aberrant diurnal cortisol rhythms in women with metastatic breast cancer. Health Psychol. 2004, 23:645-650.
38. Giese-Davis J., Wilhelm F.H., Conrad A., Abercrombie H.C., Sephton S., Yutsis M., Neri E., Taylor C.B., Kraemer H.C., Spiegel D. Depression and stress reactivity in metastatic breast cancer. Psychosom. Med. 2006, 68:675-683.
39. Giovanello K.S., Schacter D.L. Reduced specificity of hippocampal and posterior ventrolateral prefrontal activity during relational retrieval in normal aging. J. Cogn. Neurosci. 2012, 24:159-170.
40. Goto M., Abe O., Miyati T., Inano S., Hayashi N., Aoki S., Mori H., Kabasawa H., Ino K., Yano K., Iida K., Mima K., Ohtomo K. 3 Tesla MRI detects accelerated hippocampal volume reduction in postmenopausal women. J. Magn. Reson. Imaging - JMRI 2011, 33:48-53.
41. Hanseeuw B.J., Van Leemput K., Kavec M., Grandin C., Seron X., Ivanoiu A. Mild Cognitive Impairment: Differential Atrophy in the Hippocampal Subfields. AJNR - Am. J. Neuroradiol. 2011, 32:1658-1661.
42. Heck J.E., Albert S.M., Franco R., Gorin S.S. Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy. J. Am. Geriatr. Soc. 2008, 56:1687-1692.
43. Hedayati E., Alinaghizadeh H., Schedin A., Nyman H., Albertsson M. Effects of adjuvant treatment on cognitive function in women with early breast cancer. Eur. J. Oncol. Nurs. 2011, 16:315-322.
44. Hermelink K., Henschel V., Untch M., Bauerfeind I., Lux M.P., Munzel K. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study. Cancer 2008, 113:2431-2439.
45. Herrup K. Reimagining Alzheimer's disease-an age-based hypothesis. J. Neurosci. 2010, 30:16755-16762.
46. Hyrien O., Dietrich J., Noble M. Mathematical and experimental approaches to identify and predict the effects of chemotherapy on neuroglial precursors. Cancer Res. 2010, 70:10051-10059.
47. Janelsins M.C., Kohli S., Mohile S.G., Usuki K., Ahles T.A., Morrow G.R. An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin. Oncol. 2011, 38:431-438.
48. Janelsins M.C., Mustian K.M., Palesh O.G., Mohile S.G., Peppone L.J., Sprod L.K., Heckler C.E., Roscoe J.A., Katz A.W., Williams J.P., Morrow G.R. Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research. Support. Care Cancer 2012, 20:831-839.
49. Janelsins M.C., Roscoe J.A., Berg M.J., Thompson B.D., Gallagher M.J., Morrow G.R., Heckler C.E., Jean-Pierre P., Opanashuk L.A., Gross R.A. IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice. Cancer Invest. 2010, 28:544-553.
50. Jansen C.E., Miaskowski C., Dodd M., Dowling G., Kramer J. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer 2005, 104:2222-2233.
51. Jean Harry G., Bruccoleri A., Lefebvre d'Hellencourt C. Differential modulation of hippocampal chemical-induced injury response by ebselen, pentoxifylline, and TNFalpha-, IL-1alpha-, and IL-6-neutralizing antibodies. J. Neurosci. Res. 2003, 73:526-536.
52. Jenkins V.A., Ambroisine L.M., Atkins L., Cuzick J., Howell A., Fallowfield L.J. Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II). Lancet Oncol. 2008, 9:953-961.
53. Joshi G., Aluise C.D., Cole M.P., Sultana R., Pierce W.M., Vore M., St Clair D.K., Butterfield D.A. Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain. Neuroscience 2010, 166:796-807.
54. Joshi G., Hardas S., Sultana R., St Clair D.K., Vore M., Butterfield D.A. Glutathione elevation by gamma-glutamyl cysteine ethyl ester as a potential therapeutic strategy for preventing oxidative stress in brain mediated by in vivo administration of adriamycin: Implication for chemobrain. J. Neurosci. Res. 2007, 85:497-503.
55. Kates W.R., Abrams M.T., Kaufmann W.E., Breiter S.N., Reiss A.L. Reliability and validity of MRI measurement of the amygdala and hippocampus in children with fragile X syndrome. Psychiatry Res. 1997, 75:31-48.
56. Kesler S.R., Bennett F.C., Mahaffey M.L., Spiegel D. Regional brain activation during verbal declarative memory in metastatic breast cancer. Clin. Cancer Res. 2009, 15:6665-6673.
57. Kesler S.R., Garrett A., Bender B.G., Yankowitz J., Zeng S.M., Reiss A.L. Amygdala and hippocampal volumes in Turner syndrome: a high-resolution MRI study of X-monosomy. Neuropsychologia 2004, 42:1971-1978.
58. Kesler S.R., Kent J.S., O'Hara R. Prefrontal cortex and executive function impairments in primary breast cancer. Arch. Neurol. 2011, 68:1447-1453.
59. Kesler S.R., Schwartz C., Stevenson R.E., Reiss A.L. The impact of spermine synthase (SMS) mutations on brain morphology. Neurogenetics 2009, 10:299-305.
60. Konsman J.P., Vigues S., Mackerlova L., Bristow A., Blomqvist A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J. Comp. Neurol. 2004, 472:113-129.
61. Kraemer H.C., Blasey C.M. Centring in regression analyses: a strategy to prevent errors in statistical inference. Int. J. Methods Psychiatr. Res. 2004, 13:141-151.
62. Lopes, C.O., Callera, F., 2011. Three-dimensional conformal radiotherapy in prostate cancer patients: rise in interleukin 6 (IL-6) but not IL-2, IL-4, IL-5, tumor necrosis factor-alpha, MIP-1-alpha, and LIF levels. Int. J. Radiat. Oncol. Biol. Phys. 15, 1385-1388.
63. Lupien S.J., Fiocco A., Wan N., Maheu F., Lord C., Schramek T., Tu M.T. Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 2005, 30:225-242.
64. Lynch M.A. Age-related neuroinflammatory changes negatively impact on neuronal function. Front Aging Neurosci. 2010, 1:6.
65. Marsland A.L., Gianaros P.J., Abramowitch S.M., Manuck S.B., Hariri A.R. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol. Psychiatry. 2008, 64:484-490.
66. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci. Biobeh. Rev. 2009, 33:355-366.
67. McDonald B.C., Conroy S.K., Ahles T.A., West J.D., Saykin A.J. Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study. Breast Cancer Res. Treat. 2010, 123:819-828.
68. Palmer, S.C., Taggi, A., Demichele, A., Coyne, J.C., 2011. Is screening effective in detecting untreated psychiatric disorders among newly diagnosed breast cancer patients? Cancer 118, 2735-2743.
69. Phillips D.C., Woollard K.J., Griffiths H.R. The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br. J. Pharmacol. 2003, 138:501-511.
70. Phillips K.M., Jim H.S., Small B.J., Laronga C., Andrykowski M.A., Jacobsen P.B. Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls. Cancer 2012, 118:1925-1932.
71. Pickering, M., Oconnor, J., 2007. Pro-inflammatory cytokines and their effects in the dentate gyrus. Prog. Brain Res. 163, 339-354.
72. Quesnel C., Savard J., Ivers H. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study. Breast Cancer Res. Treat. 2009, 116:113-123.
73. Reiss A.L., Eckert M.A., Rose F.E., Karchemskiy A., Kesler S., Chang M., Reynolds M.F., Kwon H., Galaburda A. An experiment of nature: brain anatomy parallels cognition and behavior in Williams syndrome. J. Neurosci. 2004, 24:5009-5015.
74. Sabuncu M.R., Desikan R.S., Sepulcre J., Yeo B.T., Liu H., Schmansky N.J., Reuter M., Weiner M.W., Buckner R.L., Sperling R.A., Fischl B. The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch. Neurol. 2011, 68:1040-1048.
75. Schilder C.M., Seynaeve C., Beex L.V., Boogerd W., Linn S.C., Gundy C.M., Huizenga H.M., Nortier J.W., van de Velde C.J., van Dam F.S., Schagen S.B. Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial. J. Clin. Oncol. 2010, 28:1294-1300.
76. Seguin J.A., Brennan J., Mangano E., Hayley S. Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration. Neuropsychiatr. Dis. Treat. 2009, 5:5-14.
77. Seigers R., Fardell J.E. Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci. Biobehav. Rev. 2011, 35:729-741.
78. Seigers R., Schagen S.B., Beerling W., Boogerd W., van Tellingen O., van Dam F.S., Koolhaas J.M., Buwalda B. Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav. Brain Res. 2008, 186:168-175.
79. Seigers R., Schagen S.B., Coppens C.M., van der Most P.J., van Dam F.S., Koolhaas J.M., Buwalda B. Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav. Brain Res. 2009, 201:279-284.
80. Sephton S.E., Dhabhar F.S., Keuroghlian A.S., Giese-Davis J., McEwen B.S., Ionan A.C., Spiegel D. Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer. Brain Behav. Immun. 2009, 23:1148-1155.
81. Seruga B., Zhang H., Bernstein L.J., Tannock I.F. Cytokines and their relationship to the symptoms and outcome of cancer. Nat. Rev. Cancer 2008, 8:887-899.
82. Spiegel D., Giese-Davis J., Taylor C.B., Kraemer H. Stress sensitivity in metastatic breast cancer: Analysis of hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology 2006, 31:1231-1244.
83. Squire L.R., van der Horst A.S., McDuff S.G., Frascino J.C., Hopkins R.O., Mauldin K.N. Role of the hippocampus in remembering the past and imagining the future. Proc. Natl. Acad. Sci. USA 2010, 107:19044-19048.
84. Squire L.R., Wixted J.T. The cognitive neuroscience of human memory since H.M. Ann. Rev. Neurosci. 2011, 34:259-288.
85. Ta A.T., Huang S.E., Chiu M.J., Hua M.S., Tseng W.Y., Chen S.H., Qiu A. Age-related vulnerabilities along the hippocampal longitudinal axis 2011, Hum. Brain Mapp, http://dx.doi.org/10.1002/hbm.21364.
86. Tangpong J., Cole M.P., Sultana R., Estus S., Vore M., St Clair W., Ratanachaiyavong S., St Clair D.K., Butterfield D.A. Adriamycin-mediated nitration of manganese superoxide dismutase in the central nervous system: insight into the mechanism of chemobrain. J. Neurochem. 2007, 100:191-201.
87. Tangpong J., Cole M.P., Sultana R., Joshi G., Estus S., Vore M., St Clair W., Ratanachaiyavong S., St Clair D.K., Butterfield D.A. Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity. Neurobiol. Dis. 2006, 23:127-139.
88. Tchen N., Juffs H.G., Downie F.P., Yi Q.L., Hu H., Chemerynsky I., Clemons M., Crump M., Goss P.E., Warr D., Tweedale M.E., Tannock I.F. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J. Clin. Oncol. 2003, 21:4175-4183.
89. Troyer A.K., Rich J.B. Psychometric properties of a new metamemory questionnaire for older adults. J. Gerontol. Ser. B: Psychol. Sci. Soc. Sci. 2002, 57:P19-P27.
90. Tsukiura T., Sekiguchi A., Yomogida Y., Nakagawa S., Shigemune Y., Kambara T., Akitsuki Y., Taki Y., Kawashima R. Effects of aging on hippocampal and anterior temporal activations during successful retrieval of memory for face-name associations. J. Cogn. Neurosci. 2011, 23:200-213.
91. Vardy J. Cognitive function in breast cancer survivors. Cancer Treat. Res. 2009, 151:387-419.
92. Vardy, J.L., Booth, C., Pond, G.R., Zhang, H., Galica, J., Dhillon, H., Clarke, S.J., Tannock, I.F., 2007. Cytokine levels in patients (pts) with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function. J. Clin. Oncol. (Meeting Abstracts). 25, 9070-.
93. Viviani B., Boraso M. Cytokines and neuronal channels: a molecular basis for age-related decline of neuronal function?. Exp. Gerontol. 2011, 46:199-206.
94. Wechsler D. Wechsler Adult Intelligence Scale Fourth Edition 2008, TX, The Psychological Corporation, San Antonio.
95. Wefel J.S., Vardy J., Ahles T., Schagen S.B. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol. 2011, 12:703-708.
96. Wefel J.S., Witgert M.E., Meyers C.A. Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol. Rev. 2008, 18:121-131.
97. Wilson C.J., Finch C.E., Cohen H.J. Cytokines and cognition-the case for a head-to-toe inflammatory paradigm. J. Am. Geriatr. Soc. 2002, 50:2041-2056.
98. Wimmer M.E., Hernandez P.J., Blackwell J., Abel T. Aging impairs hippocampus-dependent long-term memory for object location in mice 2011, Neurobiol. Aging., http://dx.doi.org/10.1016/j.neurobiolaging.2011.07.007.
99. Winocur G., Vardy J., Binns M.A., Kerr L., Tannock I. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol. Biochem. Behav. 2006, 85:66-75.
100. Wolk D.A., Dickerson B.C. Fractionating verbal episodic memory in Alzheimer's disease. Neuroimage 2011, 54:1530-1539.
101. Wong, M.L., Bongiorno, P.B., al-Shekhlee, A., Esposito, A., Khatri, P., Licinio, J., 1996. IL-1 beta, IL-1 receptor type I and iNOS gene expression in rat brain vasculature and perivascular areas. Neuroreport 7, 2445-2448.
102. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011, 25:181-213.
103. You Z., Luo C., Zhang W., Chen Y., He J., Zhao Q., Zuo R., Wu Y. Pro- and anti-inflammatory cytokines expression in rat's brain and spleen exposed to chronic mild stress: Involvement in depression. Behav. Brain Res. 2011, 225:135-141.